Dr. Saul Karpen's interests lie in clinical pediatric liver disease, liver transplantation and specifically, the newborn with cholestasis. His overall goals are to develop integrative programs to improve clinical care, enhance basic hepatology research, and provide applied clinical research, including the discovery of new therapeutic agents—all focused upon the unique and pressing needs of infants and children with liver disease.